6GA-58657-99904
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 757 / TX
- Registered
- 2021-05-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-05-19
Registered in v-safe
- 2021-07-01
- 2021-09-30
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-08
- 2021-10-15
- 2021-10-24
- 2021-10-31
- 2021-11-05
- 2021-11-12
- 2021-12-31
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Very bad what i assume was a coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Very bad what i assume was a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release